Therapeutic target
Improvement of prognosis as adjuvant drug prevention after therapy of breast carcinoma by different endocrine therapy methods (about 80% of patients have a hormone-sensitive tumor) s. Breast carcinoma/medicinal therapy.
Therapy recommendations
- In Paget’s disease that is causally due to ductal carcinoma in situ (DCIS; precancerous lesion) or invasive breast carcinoma, therapy is based on the standards of the underlying disease (see Therapy of breast carcinoma)
- In the case of isolated Paget’s disease of the nipple-areola complex (nipple-areola area; < 5%), no adjuvant (additional) therapy measures are required after complete resection (R0 resection; removal of the tumor in healthy tissue; no tumor tissue is detectable in the resection margin in histopathology).
- See also under “Further therapy”.
